Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.44 (
P-glycoprotein
)
13,344
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Lysosome-associated protein transmembrane 4 alpha (
LAPTM4
alpha) and homologues comprise a family of conserved proteins, which are found in mammals, insects and nematodes.
LAPTM4
alpha functions to regulate the intracellular compartmentalization of amphipathic solutes and possibly the sensitivity of cells toward anthracyclines, antibiotics, ionophores, nucleobases and organic cations. This is similar to the multidrug-resistance phenotype exhibited by cells synthesizing high levels of
P-glycoprotein
. Accordingly, it is possible that
LAPTM4
alpha may be a suitable target for development of novel chemotherapeutic agents.
LAPTM4
alpha contains four putative membrane-spanning domains and a 55 amino acid C-terminal region that faces the cytoplasm. Localization of
LAPTM4
alpha to endosomes and lysosomes appears to be tightly controlled as transient high-level expression of
LAPTM4
alpha in cultured cells resulted in no detectable protein on the cell surface. Mutagenic analysis of the C-terminus of
LAPTM4
alpha indicated that two tandomly arranged tyrosine-containing motifs in the cytoplasmic domain are required for efficient localization of
LAPTM4
alpha to vesicles containing the lysosomal marker lysosomal glycoprotein 120. Although a number of membrane proteins that localize to endosomes/lysosomes contain more than one independently functioning sorting signal, to our knowledge,
LAPTM4
alpha is the first example of a membrane protein that requires two tandemly arranged tyrosine-based sorting signals for efficient localization in these compartments.
...
PMID:Lysosome-associated protein transmembrane 4 alpha (LAPTM4 alpha) requires two tandemly arranged tyrosine-based signals for sorting to lysosomes. 1198 May 62